# Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL)

> **NCT01120834** · PHASE1,PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 17 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** azacytidine
- **DRUG:** vorinostat

## Key facts

- **NCT ID:** NCT01120834
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-04
- **Final completion:** 2016-10-20
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-04-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01120834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01120834, "Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01120834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*